Infinium Global Research has added a new report on Alzheimer’s drugs Market. The report presents analysis of global as well as regional markets of alzheimer’s drugs market over the period of 2016 to 2024.
The rising occurrence of neurodegenerative diseases among the elderly and a healthy support from governments across developed countries has led to the development of new drugs and therapies which has helped in the development and growth of the alzheimer's drugs market. Additionally lack of Duchenne muscular dystrophy (DMD) is another factor that promotes the growth of the market. The lack of DMDs extends the treatment schedule for Alzheimer's disease, which in turn, increases the healthcare costs for patients.
Among the region North America is expected to the largest market for alzheimer’s drugs. The large number of patients suffering from the Alzheimer’s disease, high purchasing power for expensive drugs and compensation policies for the treatment of this disease is likely to boost the growth in this market. The increasing awareness about neurodegenerative diseases in Asia Pacific region will boost the growth of the global alzheimer's drugs market in the next coming years
Moreover, the growth matrix presented by Infinium Global Research identifies the key investment markets in the near future, this will not only help the companies to understand the competitive position in the global alzheimer’s drugs market but also make strategic decisions to capture the most lucrative markets in the near future. The market size is presented in terms of value for the historic year 2016 and estimated for forecast period of 2018-2024.
Get 15% discount for early purchase of global alzheimer’s drugs market report by clicking the following link, Use code IGRD15 to request the discount in the given form
https://www.infiniumglobalresearch.com/reports/request-discount/1357
The recent report identified that North America dominated the global alzheimer’s drugs market over the last couple of years, while emerging markets of Asia-Pacific and Latin America are anticipated to contribute significantly to the growth in the alzheimer’s drugs market worldwide.
The report segments the global alzheimer’s drugs market on the basis of Drug class and Distribution Channel.
Global Alzheimer’s Drugs Market by Drug Class
· Cholinergic
· Memantine
· Combined Drug
· Others
Global Alzheimer’s Drugs Market by Distribution Channel
· Hospital Pharmacy
· Retail Pharmacy
· Online Pharmacy
Companies Profiled in the Report
· H Lundbeck A/S
· Eisai Co Ltd
· Ono Pharmaceutical
· Daiichi Sankyo Company Limited
· Johnson & Johnson
· Merz Holding GmbH & Co KG
· Others
About Infinium Global Research
Infinium Global Research is a business intelligence company that provides its clients with market information services, solutions, and reports. The intelligence reports include qualitative as well as quantitative information, which are blended using forecasting models in order to project future market demand. Our panels of Subject Matter Experts (SMEs), Analysts, and Consultants use numerous data gathering tools in order to provide you with detailed information on the market as well as a preview of its projected growth. Our repository includes the largest and most credible databases, through which we determine various qualitative and quantitative parameters of the market to provide you with an in-depth business intelligence report.
Infinium Global Research reports and consulting services cover numerous sectors, which include healthcare, chemicals, materials, energy, packaged goods, food and beverages, technology, and communications. These reports provide readers with market insights and detailed analysis of market segments to possible micro levels. Our reports, with stratified research methodology and wider scope of analysis, provide clients with crucial insights and information to meet their every requirement.
